Clinical Stage III Gastric Cancer AJCC v8 Recruiting Phase 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0113386 (Clinical Stage III Gastric Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05836584Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) CancerTreatment